These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Evaluation of combinatorial vaccines against anthrax and plague in a murine model. DuBois AB; Freytag LC; Clements JD Vaccine; 2007 Jun; 25(24):4747-54. PubMed ID: 17482725 [TBL] [Abstract][Full Text] [Related]
65. Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo. Comer JE; Chopra AK; Peterson JW; König R Infect Immun; 2005 Dec; 73(12):8275-81. PubMed ID: 16299324 [TBL] [Abstract][Full Text] [Related]
66. Protection against anthrax toxemia by hexa-D-arginine in vitro and in vivo. Sarac MS; Peinado JR; Leppla SH; Lindberg I Infect Immun; 2004 Jan; 72(1):602-5. PubMed ID: 14688144 [TBL] [Abstract][Full Text] [Related]
67. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax. Sellman BR; Mourez M; Collier RJ Science; 2001 Apr; 292(5517):695-7. PubMed ID: 11326092 [TBL] [Abstract][Full Text] [Related]
71. A dominant-negative therapy for anthrax. Leppla SH Nat Med; 2001 Jun; 7(6):659-60. PubMed ID: 11385497 [No Abstract] [Full Text] [Related]
72. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis. Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170 [TBL] [Abstract][Full Text] [Related]
73. New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis. Beierlein JM; Anderson AC Curr Med Chem; 2011; 18(33):5083-94. PubMed ID: 22050756 [TBL] [Abstract][Full Text] [Related]
74. Interactions between anthrax toxin receptors and protective antigen. Scobie HM; Young JA Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864 [TBL] [Abstract][Full Text] [Related]